GENEVA, Oct. 15 -- BEIJING YOUCARE KECHUANG PHARMACEUTICAL TECHNOLOGY CO., LTD. filed a patent application (CN2026/111988) for “USE OF MEMBRANE FUSION INHIBITORY POLYPEPTIDE IN TREATMENT OR PREVENTION OF NIPAH VIRUS INFECTION”. With publication no. WO/2026/214791, here are the other details related to the patent application:
Kind: Initial Publication without ISR [A2]
IPC: A61K 38/16
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....